Medical Developments International Limited

ASX:MVP Voorraadrapport

Marktkapitalisatie: AU$57.3m

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Medical Developments International Beheer

Beheer criteriumcontroles 2/4

De CEO Medical Developments International's is Brent MacGregor, benoemd in Nov2020, heeft een ambtstermijn van 3.92 jaar. De totale jaarlijkse vergoeding van { bedraagt A$ 6.17M, bestaande uit 9.8% salaris en 90.2% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.18% van de aandelen van het bedrijf, ter waarde A$ 99.61K. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 4.2 jaar en 3.8 jaar.

Belangrijke informatie

Brent MacGregor

Algemeen directeur

AU$6.2m

Totale compensatie

Percentage CEO-salaris9.8%
Dienstverband CEO3.9yrs
Eigendom CEO0.2%
Management gemiddelde ambtstermijn4.2yrs
Gemiddelde ambtstermijn bestuur3.8yrs

Recente managementupdates

Recent updates

Positive Sentiment Still Eludes Medical Developments International Limited (ASX:MVP) Following 27% Share Price Slump

May 13
Positive Sentiment Still Eludes Medical Developments International Limited (ASX:MVP) Following 27% Share Price Slump

Is Medical Developments International (ASX:MVP) In A Good Position To Invest In Growth?

May 03
Is Medical Developments International (ASX:MVP) In A Good Position To Invest In Growth?

Why Investors Shouldn't Be Surprised By Medical Developments International Limited's (ASX:MVP) 28% Share Price Plunge

Mar 11
Why Investors Shouldn't Be Surprised By Medical Developments International Limited's (ASX:MVP) 28% Share Price Plunge

Medical Developments International Limited (ASX:MVP) Soars 28% But It's A Story Of Risk Vs Reward

Jan 16
Medical Developments International Limited (ASX:MVP) Soars 28% But It's A Story Of Risk Vs Reward

Will Medical Developments International (ASX:MVP) Spend Its Cash Wisely?

Jan 03
Will Medical Developments International (ASX:MVP) Spend Its Cash Wisely?

Is Medical Developments International (ASX:MVP) In A Good Position To Deliver On Growth Plans?

Aug 09
Is Medical Developments International (ASX:MVP) In A Good Position To Deliver On Growth Plans?

We're Keeping An Eye On Medical Developments International's (ASX:MVP) Cash Burn Rate

Apr 24
We're Keeping An Eye On Medical Developments International's (ASX:MVP) Cash Burn Rate

Is Medical Developments International (ASX:MVP) In A Good Position To Deliver On Growth Plans?

Jul 04
Is Medical Developments International (ASX:MVP) In A Good Position To Deliver On Growth Plans?

Some Analysts Just Cut Their Medical Developments International Limited (ASX:MVP) Estimates

Mar 04
Some Analysts Just Cut Their Medical Developments International Limited (ASX:MVP) Estimates

Medical Developments International Limited (ASX:MVP) Analysts Just Slashed This Year's Estimates

Mar 05
Medical Developments International Limited (ASX:MVP) Analysts Just Slashed This Year's Estimates

If You Had Bought Medical Developments International (ASX:MVP) Shares Five Years Ago You'd Have Earned 56% Returns

Feb 07
If You Had Bought Medical Developments International (ASX:MVP) Shares Five Years Ago You'd Have Earned 56% Returns

Don't Ignore The Fact That This Insider Just Sold Some Shares In Medical Developments International Limited (ASX:MVP)

Dec 16
Don't Ignore The Fact That This Insider Just Sold Some Shares In Medical Developments International Limited (ASX:MVP)

Medical Developments International Limited's (ASX:MVP) Has Been On A Rise But Financial Prospects Look Weak: Is The Stock Overpriced?

Dec 10
Medical Developments International Limited's (ASX:MVP) Has Been On A Rise But Financial Prospects Look Weak: Is The Stock Overpriced?

Analyse CEO-vergoeding

Hoe is Brent MacGregor's beloning veranderd ten opzichte van Medical Developments International's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Jun 30 2024AU$6mAU$602k

-AU$41m

Mar 31 2024n/an/a

-AU$30m

Dec 31 2023n/an/a

-AU$19m

Sep 30 2023n/an/a

-AU$12m

Jun 30 2023AU$2mAU$576k

-AU$6m

Mar 31 2023n/an/a

-AU$4m

Dec 31 2022n/an/a

-AU$2m

Sep 30 2022n/an/a

-AU$7m

Jun 30 2022AU$2mAU$547k

-AU$12m

Mar 31 2022n/an/a

-AU$16m

Dec 31 2021n/an/a

-AU$19m

Sep 30 2021n/an/a

-AU$16m

Jun 30 2021AU$1mAU$351k

-AU$13m

Compensatie versus markt: De totale vergoeding ($USD 4.26M ) Brent } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de Australian markt ($USD 313.13K ).

Compensatie versus inkomsten: De vergoeding van Brent is gestegen terwijl het bedrijf verliesgevend is.


CEO

Brent MacGregor (60 yo)

3.9yrs

Tenure

AU$6,166,500

Compensatie

Mr. Brent MacGregor serves as an Independent Director at Dynavax Technologies Corporation since July 2020. He has been the Chief Executive Officer of Medical Developments International Limited since Novemb...


Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Brent MacGregor
Chief Executive Officer3.9yrsAU$6.17m0.18%
A$ 101.9k
Anita James
Chief Financial Officer2.4yrsAU$5.94m0.049%
A$ 28.3k
Matthew Cramer
Chief of Operations & Supply Chain4.8yrsgeen gegevensgeen gegevens
Scott Courtney
Chief Scientific Officer5.3yrsgeen gegevensgeen gegevens
Tara Eaton
General Counsel & Company Secretary2.2yrsgeen gegevensgeen gegevens
Wai Chi
Head of Regulatory Affairs5.9yrsgeen gegevensgeen gegevens
Wayne Pearce
Head of Production4.3yrsgeen gegevensgeen gegevens
Stefaan Schatteman
Head of Europe4.2yrsgeen gegevensgeen gegevens

4.2yrs

Gemiddelde duur

Ervaren management: Het managementteam van MVP wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.2 jaar).


Bestuursleden

NaamPositieTenureCompensatieEigendom
Gordon Naylor
Non-Executive Chairman4yrsAU$95.00k1.03%
A$ 589.0k
Mary Sontrop
Non-Executive Director3.6yrsAU$60.00k0.016%
A$ 9.3k
Russell Basser
Non-Executive Director1.1yrsAU$50.00k0.012%
A$ 7.1k
Leon Hoare
Non-Executive Director11.1yrsAU$60.00k0.049%
A$ 27.9k
Richard Betts
Non-Executive Director3.4yrsAU$60.00k0.018%
A$ 10.5k
Christine Emmanuel-Donnelly
Non-Executive Director4.4yrsAU$60.00k0.071%
A$ 40.8k

3.8yrs

Gemiddelde duur

Ervaren bestuur: De raad van bestuur van MVP wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.8 jaar).